FDA Orders Warnings Added to Avandia Packaging

On May 21, 2007, the Food and Drug Administration issued a public safety alert about the diabetes drug Avandia, warning users of the greatly increased risk of heart failure in people taking the drug. The notice came on the heels of a New England Journal of Medicine study, which found people who took the drug had a 43% increase in the risk of heart attack and a 64% increase in the risk of death from all cardiovascular causes.

The FDA also ordered Avandia’s maker, GlaxoSmithKline, to add a prominent “Black Box” warning to the drug’s packaging to tell users about the increased risks of congestive heart failure and cardiovascular disease.

The FDA warnings also cautioned Type 2 diabetes patients who have underlying heart disease or are at high risk of heart attack to talk with their health care provider about their treatment options. Physicians and other health care providers were cautioned to closely monitor patients who take Avandia for cardiovascular risks.

Avandia Legal Advice is Available

Type 2 diabetes patients who experienced heart failure or another injury after taking Avandia may have legal rights. At Mark & Associates, P.C., our attorneys are experienced at handling Avandia claims. Contact Mark & Associates, P.C. today for a free consultation about your potential case. Call 1-866-50-RIGHTS (1-866-507-4448) or simply fill out the form at the right.

Have You Taken Avandia & Suffered Serious Injury| You May Be Entitled to Compensation

Click Here to Call TOLL-FREE
Chat Immediatley By Clicking Here

First Name

Last Name

Email Address

Phone Number

Cell Phone Number

Street Address

City

State

Zip Code

Date of birth of injured person (mm/dd/yyyy):

Date you were prescribed Avandia (mm/dd/yyyy):

Dates Avandia (rosiglitazone) was used (mm/dd/yyyy)

Was a heart attack suffered while taking Avandia? Yes No

If yes, indicate date of heart attack:

Please further describe injuries from Avandia:

Please describe Avandia related problems:

Other Comments:

By submitting this form I agree to the following disclaimer.